News

Jomaa Pharma Endorses Project Premonition

Project Premonition aims to detect pathogens before they cause outbreaks and may help to map drug-resistant malaria parasite strains.

Read more …

Jomaa Collaborates with Alfred E Tiefenbacher GmbH & Co KG

World Malaria Day 2017: Jomaa Pharma GmbH are pleased to announce their collaboration with Alfred E Tiefenbacher GmbH & Co KG in a Joint Venture

Read more …

Jomaa Presents Clinical Study Results

Jomaa Pharma GmbH today announced the presentation of the results of its recently completed clinical study In Gabon to treat acute malaria with its Non-Artemisinin-based Combination Therapy.

Read more …

The Hamburg Malaria Project

Jomaa Pharma is developing a new drug against the malicious tropical disease – supported by Hamburg merchants. The perspectives are promising.

Read more …

Clinical Update

Clinical study in Gabon shows high efficacy of the fosmidomycin-piperaquine combination in the treatment of malaria.

Read more …

Action and Investment to defeat Malaria 2016–2030 (AIM)

Action and Investment to defeat Malaria 2016–2030 (AIM) – for a malaria-free world builds on the success of the first Global Malaria Action Plan – for a malaria-free world.

Read more …

World Malaria Day 2016

Jomaa Pharma's Drug Candidate proves 100% cure rate in children below the age of five years

 

Read more …

Global Technical Strategy for Malaria 2016–2030

 The WHO sets the target of reducing global malaria incidence and mortality rates by at least 90% by 2030.

Read more …

Jomaa Pharma - Medicines for Malaria Venture Collaboration

Jomaa Pharma and Medicines for Malaria Venture sign Letter of Understanding

Read more …